Introduction
The activator protein-1 (AP-1) complex is crucial in the regulation of proliferation, transformation and cell death (Shaulian and Karin, 2001; Eferl and Wagner, 2003) . The c-Jun oncoprotein is the most prevalent component of the AP-1 transcription factor complex and is tightly regulated by phosphorylation at multiple sites mediated by several kinases. Among these kinases, the c-Jun N-terminal kinases (JNKs) phosphorylate c-Jun at its N-terminus, which promotes c-Jun transcriptional activation (Weiss et al., 2003) , DNA-binding activity (Papavassiliou et al., 1995) and protects c-Jun from degradation (Musti et al., 1997) . Although c-Jun is known to become more stable after phosphorylation at the N-terminus, the underlying mechanism for the reduced c-Jun ubiquitination and degradation is not known.
Three ubiquitin ligases were reported to induce the ubiquitination and degradation of c-Jun. One ligase is the human COP1, which forms a multi-subunit ubiquitin ligase complex, DCX hDET1ÀhCOP1 and promotes c-Jun degradation regardless of c-Jun's phosphorylation status (Wertz et al., 2004) . A second ligase is Itch, whose E3 ligase activity needs to be activated by JNKs through phosphorylation, causing the degradation of c-Jun in a manner independent of c-Jun phosphorylation by JNKs (Gao et al., 2004) . The third c-Jun E3 ligase is Fbw7 (also called Fbxw7, CDC4, AGO and SEL10; Nateri et al., 2004) , which forms a ligase complex with SKP1 and CUL1 that is referred to as SCF FBW7 (Welcker and Clurman, 2008) . Phosphorylation of the C-terminus of c-Jun (Thr239) by GSK3b (Wei et al., 2005) is required for c-Jun to be recognized by Fbw7 for degradation.
Receptor for activated C-kinase 1 (Rack1) is an adaptor protein that has seven WD40 domains. Through its WD40 domains, Rack1 can bind one or two other molecules to form a complex that has an important role in various cellular functions (Schechtman and Mochly-Rosen, 2001 ). For example, Rack1 functions as an adaptor protein between activated protein kinase C and JNKs to enhance JNKs phosphorylation (Lopez-Bergami et al., 2005) and regulates translation as a component of the 80S ribosome (Sengupta et al., 2004) . Rack1 also promotes degradation of HIF1a (Liu et al., 2007) and BimEL (Zhang et al., 2008) by mediating the interaction between each of these proteins and the ubiquitin complex. Importantly, accumulating clinical data indicate that Rack1 is involved in cancer cell proliferation, invasion and metastasis, and is a novel biomarker for diagnosis and prognosis prediction (Wang et al., 2008; Nagashio et al., 2009; Cao et al., 2009a Cao et al., , 2009b . These types of findings suggest that more studies are needed to increase our understanding as to how Rack1 functions in carcinogenesis.
Herein, we report that Rack1 promotes cell transformation by enhancing oncogenic c-Jun stability. We observed that Rack1 can bind with c-Jun and Fbw7 E3 ligase to form a complex. Most interestingly, Rack1 functions as an adaptor protein to recruit non-phosphorylated c-Jun proteins to the complex, but exclude N-terminal phosphorylated c-Jun from the complex. Therefore, the N-terminal phosphorylated c-Jun exhibits increased stability due to reduced ubiquitination and degradation in the presence of Rack1. Thus, we provide evidence to explain the significance of Rack1 as an important participant in tumorigenesis.
Results

Rack1 promotes cell transformation by maintaining c-Jun protein abundance
Rack1 is highly expressed in many cancers, including pulmonary adenocarcinoma (Nagashio et al., 2009) , colon carcinoma (Berns et al., 2000) , melanoma (Egidy et al., 2008) and breast carcinoma (Cao et al., 2009a, b) . In order to elucidate the role of Rack1 in tumorigenesis, the JB6 C141 (promotion sensitive, P þ ) mouse skin epidermal cell line (Bernstein and Colburn, 1989 ) was used. We first knocked down Rack1 expression in JB6 cells by using siRNA that targets Rack1 (siRack1; Figure 1a left, inset). We found that siRack1 cells grew significantly slowly than siMock cells (Figure 1a left) and colony formation of siRack1 cells induced by epidermal growth factor (EGF) on soft agar was also markedly suppressed ( Figure 1a , middle and right). To avoid the possibility of off-target effects, we established additional stable JB6 cells (shMock and shRack1-1, shRack1-2) using lentivirus that included the different targeting sequences. The observed results are similar to those shown in Figure 1a (Supplementary Figures S1A, B, C) .
To observe the function of Rack1 in vivo, we knocked down Rack1 in HCT116 colorectal cancer cells. After Rack1 knockdown, proliferation and colony formation on soft agar were decreased (Supplementary Figures S2A, B) . When HCT116 siMock or siRack1 cells were subcutaneously injected into mice, tumor formation of siRack1 HCT116 cells was significantly suppressed compared with siMock HCT116 cells (Figure 1b ). These data confirmed that Rack1 has a very important role in tumorigenesis.
EGF-induced AP-1 activity is critical for transformation of JB6 cells (Dong and Colburn, 1994) . Using an AP-1 luciferase reporter gene assay, we found that AP-1 activity is very low in siRack1 cells even after EGF stimulation (Figure 1c) . To determine the role of Rack1 in EGF signaling, we examined EGF-induced mitogenactivated protein (MAP) kinase signaling in siMock and siRack1 JB6 cells. These results indicated that the phosphorylation of extracellular signal-regulated kinases, a major MAP kinase in EGF signaling, is similar in the two cell types (Figure 1d , upper panels), which is consistent with at least one other report (Vomastek et al., 2007) . However, we found that the abundance of the c-Jun protein is substantially decreased in siRack1 cells compared with siMock cells (Figure 1d , upper panels), whereas the levels of other components found in the AP-1 complex, including JunB and c-Fos were similar (Figure 1d , upper panels). These results suggested that lower c-Jun protein abundance is at least partially responsible for the attenuated AP-1 activity in Rack1 knockdown cells. After treatment of cells with ultraviolet B or anisomysin, we also observed that the low c-Jun level in siRack1 cells is a general phenomenon (Supplementary Figure S2C) . Others have reported that JNKs activity is decreased after Rack1 knockdown (Lopez-Bergami et al., 2005) . However, our results indicated that Rack1 knockdown in JB6 cells had no effect on JNKs phosphorylation or JNKs activity toward its substrate ATF2 (Supplementary Figure S2C ), which suggested that the low c-Jun protein level is not related to JNKs activity in JB6 cells.
Next, we determined the effect of Rack1 on c-jun mRNA expression. c-Jun is regarded as an 'early response gene' and its expression can be induced very quickly by growth factors. Using reverse transcription-PCR, we found that the level of c-jun mRNA is increased by EGF in both siMock and siRack1 cells (Figure 1d , lower panel). Although the expression of cjun mRNA appears to be slightly lower in siRack1 cells, the level does not correspond well with the extremely low c-Jun protein abundance observed in these cells. Overall, these results suggest that Rack1 might promote cell transformation by maintaining a high level of the c-Jun protein.
Rack1 promotes H-Ras G/12V
-induced foci formation and maintains c-Jun protein stability We used the H-Ras G12/V -mediated foci formation assay as another neoplastic transformation system to study the function of Rack1 because H-Ras G12/V -initiated signaling is predominant in many cancer cell types (Schubbert et al., 2007) . We found that Rack1 overexpression slightly promotes foci formation, whereas knockdown of Rack1 (Supplementary Figure S3A) markedly suppresses foci formation (Figure 2a) . Also, after Rack1 knockdown, H-Ras G12/V -induced AP-1 activity was reduced (Figure 2b ). These data suggest that Rack1 promotes H-Ras G12/V -induced foci formation possibly by maintaining AP-1 activity.
We next established stable Rack1 knockdown in NIH3T3 cells (shRack1; Supplementary Figure S3B , inset), by using the lentivirus as for Supplementary Figure S1 . Similarly, shRack1 cells grew more slowly (Supplementary Figure S3B) , and the c-Jun protein abundance was lower in shRack1 cells compared with shMock cells (Figure 2c , upper panel). However, the c-jun mRNA levels were similar in two cell types after EGF stimulation (Figure 2c , lower panel). Taken together, these results strongly support the idea that the low c-Jun protein abundance might be associated with the stability of c-Jun protein.
We next examined the stability of c-Jun in shMock and shRack1 cells after treatment with cycloheximide, which prevents new protein synthesis. We found that the half-life of c-Jun is shorter in shRack1 cells compared with shMock cells (Figure 2d 
Rack1 binds with the Fbw7 E3 ligase
Fbw7 is a primary E3 ligase that mediates c-Jun degradation. It has eight WD40 domains. Rack1 has seven WD40 domains. Others have reported that WD40 domains can interact with each other. For example, Rack1 can form a homodimer through an interaction between WD40 domains (Thornton et al., 2004) . Therefore, we hypothesized that Rack1 might be able to bind with Fbw7. The binding was detected in HEK293T cells (Figure 3d , left panel) and also confirmed by an in vitro glutathione S transferase pulldown assay (Figure 3d, right panel) .
Rack1 recruits the non-phosphorylatable c-Jun into the complex and excludes the phospho-mimetic c-Jun from the complex A previous study showed that the binding between Fbw7 and c-Jun is dependent on c-Jun C-terminal phosphorylation at Thr239 and Ser243 (Wei et al., 2005) . Whether the N-terminal phosphorylation status of c-Jun affects its binding with Fbw7 is not known. We overexpressed c-Jun and Fbw7 in HEK293T cells and treated the cells with anisomycin. We found that anisomycin treatment causes a slower migration of the c-Jun protein (Figure 4a Rack1 maintains the stability of phosphorylated c-Jun J Zhang et al suggested that the complex is most stable when c-Jun is in an N-terminus non-phosphorylatable form and the complex is less stable when c-Jun is in the N-terminus phospho-mimetic form.
Next, we determined whether C-terminus phosphorylation of c-Jun at Thr239 and Ser243 has an effect on the complex. The data showed that the binding between Fbw7 and c-Jun is almost abolished in a mutant AF-c-Jun (Thr239 and Ser243 changed to alanine and phenylalanine, respectively; Figure 4c , lane 4 vs 2) agreeing with a previous report (Wei et al., 2005) . When c-Jun is a wild type form, c-Jun and Rack1 can be detected in the Fbw7 precipitate (Figure 4c These results were confirmed in cells expressing endogenous c-Jun and Rack1. Flag-Fbw7 was transfected into NIH3T3 cells and cells were treated with anisomycin and harvested. Endogenous c-Jun and Rack1 could be detected in the Flag-Fbw7 precipitate from untreated cells, but not in cells treated with anisomycin (Figure 4d ).
Rack1 promotes c-Jun
Ala ubiquitination, but suppresses c-Jun Asp ubiquitination and the half-life of c-Jun Asp is shorter in shRack1 cells compared with shMock cells Our data suggest a difference in the ability of the N-terminal non-phosphorylatable and phosphorylated forms of c-Jun to bind with Fbw7. Whether this difference also results in dissimilarity in ubiquitination for c-Jun mediated by Fbw7 is unknown. We transfected various combinations of the different forms of c-Jun, GSK3b, Fbw7 and Rack1 into 293T cells and performed an in vivo ubiquitination assay. The results show that Rack1 alone can promote wild-type c-Jun ubiquitination (Figure 5a, compare lanes 2 and 3) . The GSK3b-Fbw7 degradation pathway promotes the ubiquitination of all three forms of c-Jun, including wildtype, c-Jun Ala and c-Jun Asp (Figure 5a , lanes 4, 7 and 10). c-Jun Ala seems to exhibit the most ubiquitination, whereas c-Jun Asp shows much less ubiquitination than either wild-type c-Jun or c-Jun Ala . Consistent with our hypothesis, Rack1 promotes ubiquitination of wild-type c-Jun or c-Jun
Ala , but suppresses c-Jun Asp ubiquitination (Figure 5a, lanes 5, 8 and 11) .
The question as to why c-Jun that has been phosphorylated at the N-terminus by JNKs or other Rack1 maintains the stability of phosphorylated c-Jun J Zhang et al kinases is more stable has long been unanswered (Musti et al 1997) . The effect of Rack1 on the ubiquitination of c-Jun Asp led us to hypothesize that Rack1 might have a very important role in protecting the N-terminus phosphorylated c-Jun from degradation. We transfected the phospho-mimick c-Jun Asp into shMock or shRack1 cells to assess the effect of Rack1 on the halflife of c-Jun Asp . We found that the half-life of c-Jun Asp was much shorter in shRack1 cells compared with shMock cells (Figure 5b ). This indicates that phosphorylated c-Jun will be unstable if the abundance of the Rack1 protein is low, and implies that Rack1 is important in maintaining the stability of the N-terminal phosphorylated c-Jun.
Endogenous N-terminal phosphorylated c-Jun is unstable after Rack1 knockdown and its degradation is mediated by the Fbw7 ubiquitin ligase In order to further clarify whether Rack1 knockdown affects the stability of endogenous N-terminal phosphorylated c-Jun, we performed experiments following a design described previously (Musti et al., 1997) . We first treated shMock and shRack1 cells with anisomycin for 15 min to induce N-terminal JNKs phosphorylation of c-Jun, and then we changed the medium to fresh medium containing cycloheximide and anisomycin. Cells were harvested at different time points and the half-life of N-terminal phosphorylated c-Jun was examined. Results indicated that the half-life of endogenous phosphorylated c-Jun was shorter in shRack1 cells compared with shMock cells (Figure 6a ). To determine whether N-terminal phosphorylated c-Jun is degraded by E3 ligase Fbw7 in shRack1 cells, we compared the half-life of phosphorylated c-Jun in shRack1 cells transfected with an shMock or shFbw7 plasmid (Popov et al 2007) . The result shows that knockdown of Fbw7 can extend the half-life of phosphorylated c-Jun (Figure 6b ), suggesting that Fbw7 is the E3 ligase responsible for targeting the N-terminal phosphorylated c-Jun for degradation in vivo. Finally, we determined whether Fbw7 knockdown can rescue the decreased foci formation caused by Rack1 knockdown. We first confirmed that knockdown of Rack1 inhibits foci formation (Figure 6c , upper right panel) similar with the result shown in Figure 2a . Notably, knocking down both Rack1 and Fbw7 reverses the decreased foci formation (Figure 6c, lower right  panel) . This demonstrated that the inhibition of foci formation by Rack1 knockdown is caused by an increased degradation of N-terminal phosphorylated cJun, which is mediated by Fbw7. Thus, the role of Rack1 is to protect the N-terminal phosphorylated cJun from degradation, maintaining the activity of the AP-1 complex.
Discussion
The c-Jun oncoprotein can cooperate with Ha-ras to transform fibroblasts Smeal et al., 1991) . Skin tumorigenesis was suppressed in the two-stage skin carcinogenesis model using a dominant-negative cJun (TAM67) transgenic mouse (Young et al., 1999) . Cancer cells appear to have several ways to maintain a high level of c-Jun. For example, the mutant Ras can promote MAP kinase signaling, which induces c-Jun transcriptional expression. Constitutively active MAP kinase signaling, and especially JNKs, in cancer cells can result in a hyper-phosphorylation of c-Jun at its N-terminus to protect c-Jun from degradation. v-Jun, the viral counterpart of c-Jun, has a phenyalanine residue instead of serine at the 243 site, which allows v-Jun to avoid recognition by Fbw7, resulting in increased stability of v-Jun (Wei et al., 2005) . Many cancer cells harbor an Fbw7 gene deletion or mutation, so that c-Jun cannot be degraded in these cell types (Welcker and Clurman, 2008) . Understanding the complexity of c-Jun stability can assist in the design of different strategies to decrease the abundance of c-Jun to suppress carcinogenesis.
Compelling evidence has been provided showing that Fbw7 is the E3 ligase for c-Jun and its function is Rack1 maintains the stability of phosphorylated c-Jun J Zhang et al believed to be dependent on phosphorylation of the C-terminus of c-Jun (Wei et al., 2005) . Herein, we found that phosphorylation of c-Jun at its N-terminus also can influence the binding of Fbw7 and c-Jun (Figure 4a) . Importantly, Rack1 acts as an adaptor protein that selectively binds N-terminal non-phosphorylated c-Jun along with Fbw7 (Figures 3b-d) . Further results suggest the formation of a complex comprised of Fbw7, N-terminal non-phosphorylatable ac-Jun and Rack1 (Figures 4b and c) . This complex facilitates the ubiquitination of c-Jun by Fbw7 (Figure 5a ). When c-Jun is phosphorylated at its N-terminus by JNKs or other kinases, the complex with Rack1 and Fbw7 cannot be formed and thus c-Jun is protected from degradation ( Figure 4b ). This mechanism begins to unravel the puzzle as to why c-Jun is stable after phosphorylation at its N-terminus by JNKs or other kinases.
Another question that needed to be addressed is the identification of the E3 ligase that functions in the degradation of N-terminal phosphorylated c-Jun in the absence of Rack1. In Rack1 knockdown cells, JNKsphosphorylated c-Jun is unstable, which means that an E3 ligase is still functioning to target the N-terminal (Figure 6a ), whereas knockdown of Fbw7 can suppress the degradation of JNKs-phosphorylated c-Jun (Figure 6b) . Hao et al. (2007) reported that Fbw7 forms a homodimer to efficiently degrade the substrates. Therefore, we speculate that, in Rack1 highly expressed cells, Rack1 might form the heterodimer with Fbw7 through WD40 domain's interactions, resulting in the binding of more N-terminal non-phosphorylated c-Jun, but less N-terminal phosphorylated c-Jun. Without Rack1, Fbw7 forms homodimer, which binds c-Jun regardless of the phosphorylation status at the N-terminus, thereby targeting N terminal phophorylated c-Jun for degradation.
Rack1 is highly expressed in many kinds of cancers and is involved in proliferation, survival and metastasis of cancer cells. We found that neoplastic transformation is markedly suppressed by knockdown of Rack1 in JB6 cells, and this finding was verified in the in vivo tumor formation model using HCT116 colorectal cancer cells and the H-Ras G12/V -mediated foci formation system. Therefore, our findings suggested the overactive MAP kinase signaling in cancer cells promotes a high level of Rack1 expression (Lopez-Bergami et al., 2007) , which protects N-terminal phosphorylated c-Jun from degradation. This positive feedback loop maintains a high AP-1 activity, which is important for cancer cells to sustain a transformation phenotype.
Materials and methods
Cell lines and antibodies JB6 C141, NIH3T3 cells, HEK293T and HCT116 cells were purchased from American Type Culture Collection (ATCC). Cells were resuscitated from early passage frozen stocks, and cultured following the procedures provided by ATCC. Cell Rack1 maintains the stability of phosphorylated c-Jun J Zhang et al lines were routinely verified by growth curve, morphology and soft agar assays. JB6 C141 cells or HCT116 cells were transfected with siMock or siRack1 plasmids using jetPEI (Qbigene, Carlsbad, CA, USA). Cells were transferred into 10-cm dishes for G418 (400 mg/ml) selection and then siRack1 cells were picked from single colonies. Stable JB6 or NIH3T3 shRack1 cells were established using lentivirus particles. After 24 hinfection, culture media were changed to selection media that included puromycin (3 mg/ml). Antibodies to detect Rack1, c-Fos, JunB, H-Ras and phosphorylated c-Jun were from Santa Cruz Biotechnology, Inc., (Santa Cruz, CA, USA). The antibody to immunoprecipitate Rack1 was from BD Transduction Laboratories (Sparks, MD, USA). Anti-c-Jun and anti-phospho-c-Jun were from Cell Signaling Technology, Inc. (Danvers, MA, USA). Anti-Flag and the peroxidaseconjugated anti-Flag were from Sigma-Aldrich (St Louis, MO, USA). Antibodies against Xpress, V5 and green fluorescent protein were from Invitrogen (Carlsbad, CA, USA).
Constructs
The targeting sequence of the siRack1 pU6 vector is 5 0 -GGCA AGCACCTCTACACTT-3 0 and the siMock pU6 vector (Yu et al., 2002) includes the scrambled sequence as described previously (Cho et al., 2009 (Stambolic and Woodgett, 1994) and the shFbw7 knockdown vector (Popov et al., 2007) were from Addgene (Cambridge, MA, USA).
AP-1 luciferase reporter gene assay
The constructs of the AP-1 luciferase reporter gene, together with pRL-SV40 were transfected into cells and 24 h later, cells were serum-starved, then disrupted with lysis buffer (Dual Luciferase Reporter Assay System, Promega, Madison, WI, USA) at room temperature for 1 h with gentle shaking. Cell lysates were analyzed for firefly luciferase activity.
MTS assay
To estimate proliferation, cells were seeded into 96-well plates in 100 ml of medium. At various time points, MTS solution (Celltiter 96 Aqueous One Solution, Promega) was added to each well. Absorbance at OD492 was read to estimate proliferation. Protein degradation and ex vivo ubiquitination Cells were treated with (cycloheximide 40 mg/ml), harvested at different time points and subjected to western blot to detect the abundance of the c-Jun protein. For the ex vivo ubiquitination assay, the constructs expressing Flag-tagged ubiquitin were co-transfected with other plasmids as indicated. Before harvesting, cells were treated with MG132 (20 mM) for 6 h to induce accumulation of ubiquitinated protein. Then the cell lysates were subjected to immunoprecipitation using anti-V5 and the precipitate was analyzed by immunoblotting with horseradish peroxidase-conjugated Flag antibody to visualize ubiquitination.
In vivo tumor growth Athymic mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA). The mice were divided into two groups (n ¼ 15) and injected in the right flank with siMock or siRack1 HCT116 colorectal cancer cells (1 Â 10 6 ). Tumors were measured by caliper twice a week. All studies were performed in accordance with the guidelines approved by the University of Minnesota Institutional Animal Care and Use Committee.
Anchorage-independent colony formation soft agar and Foci formation assays siMock-and siRack1-JB6 cells were exposed to EGF (10 ng/ ml) in 1 ml of 0.3% basal medium Eagle's agar/10% fetal bovine serum. siMock-and siRack-HCT116 cells were not exposed to EGF. Colonies from JB6 cells were counted after 10 days, those from HCT116 cells were counted after 5 days. The foci formation assay was performed following a standard protocol (Clark et al., 1995) .
Statistical analysis
Statistical differences were determined using the Student's t-test or one-way analysis of variance and a P-value of o0.05 was considered significant.
